May 19th, 2026
The integrated stress response in cells acts to reduce protein synthesis while enhancing maintenance activities. A number of sensors for different forms of cell stress all converge on activation of the integrated stress response. These stresses include lack of nutrients, the presence of viral material, and too many unfolded proteins cluttering up the endoplasmic reticulum, among others. The degree of activation of the integrated stress response is important: mild activation is generally beneficial, but too much activation will produce apoptosis, the cell destroying itself in programmed cell death.
Like other stress response systems in the cell, some studies show that manipulation of the integrated stress response can modestly slow aging and extend life in short-lived species. Thus there is considerable research interest in the manipulation of the integrated stress response as a basis for therapy. A number of drugs capable of promoting or suppressing the integrated stress response exist already, and others are in development. The challenge in targeting the integrated stress response lies in the threading the needle of settling on enough activation to be useful, but not too little activation or too much activation, either of which can be harmful. What constitutes the right level of integrated stress response activation may vary between cell types in a tissue, between different tissues, and between individuals. Thus integrated stress response targeting drugs tend to have unpleasant side effect profiles.
